Abstract. Breast cancer (BrC) is a major public health problem worldwide. The intra-tumoral heterogeneity and tumor cell plasticity importantly contribute to disease progression and treatment failure. However, the dynamic interactions between different tumor clones, as well as their contribution to tumor aggressiveness are still poorly understood. In this study, we provide evidence of a lateral transmission of aggressive features between aggressive and non-aggressive tumor cells, consisting of gain of expression of cancer stem cell markers, increased expression of CXCL12 receptors CXCR4 and CXCR7 and increased invasiveness in response to CXCL12, which correlated with high levels of secretion of pro-inflammatory mediators G-CSF, GM-CSF, MCP-1, IL-8 and metalloproteinases 1 and 2 by the aggressive cells. Noteworthy, we found no evidence of a TGF-β participation in the inducible-invasive phenotype. Altogether, our results provide evidence of communication between tumor cells with different potentials for aggressiveness, which could influence intra-tumoral population dynamics promoting the emergence of clones with novel functions. Understanding these interactions will provide better targets for diagnosis, prognosis and therapeutic strategies.
Introduction
Cancer is one of the leading human health problems worldwide. Since the term includes an extensive variety of different diseases, there are still many types of cancer with a dismal prognosis. Breast cancer (BrC) is the most common cause of cancer in working age women. Since most cases are diagnosed at advanced stages, BrC mortality is particularly high in underdeveloped countries (1, 2) . Similar to most cancers, BrC is a highly heterogeneous disease, and although we currently have several classification and staging strategies to distinguish BrC sub-types with variable clinical outcomes, diseases originally thought as non-aggressive are often treatment resistant or relapse with highly aggressive characteristics (3) . BrC cells also exhibit a large genetic and epigenetic intra-tumoral heterogeneity, conferring individual cells with specific immunosuppressive, proliferative, survival, metabolic, and invasive characteristics, that signal specific tumor clones with cancer dissemination and treatment resistance capacities (4) . Furthermore, tumor clones are surrounded by a highly dynamic microenvironment formed by tumor-associated macrophages, neutrophils, T-cells, NK cells, fibroblasts, among other cells (the tumor microenvironment or TME). Although, in recent years we have seen a hefty increase in our understanding of critical interactions between tumor cells and TME cells, that has propelled the design of therapeutic molecular inhibitors (5), we significantly lack behind in our comprehension of relevant interactions between tumor clones with different aggressive features and the impact of these interactions on disease progression and prognosis.
Miller et al in a 1983 hallmark study observed that there is cooperation between metastatic and non-metastatic tumor clones. This group reported in a syngeneic mouse model that the presence of a metastatic subpopulation enabled non-mobile subpopulations to metastasize (6) . More recently, a similar observation was also made by Calbo et al (7) . Experiments using the Drosophila melanogaster (fruit fly) in which different cells were engineered to express either RAS V12 or scrib -common oncogenic mutations, revealed intra-clonal cooperation that promoted tumor growth and invasion (8) . Similarly, Cleary et al observed in a mouse model of BrC that two different cellular clones had to be transferred to propagate the tumor in new mice, one clone with an Hras genetic mutation and the other with the capacity to secrete high levels of the
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Wnt1 signaling molecule but harboring a wild-type Hras (9) . Soluble factors secreted by chemoresistant tumor cells and also by cancer stem cells (CSCs) promote resistance of chemosensitive cancer cells (10) . Moreover, Mukherjee et al showed that non-migratory CSCs confer metastatic potential to non-CSCs (11) . Understanding the origin of intra-tumoral heterogeneity is one of the greatest challenges nowadays. There is evidence supporting tumor cell plasticity to microenvironmental stimuli and to genetic and epigenetic changes. differentiated tumor cells seem able to acquire stem cell-like properties, and conversely, CSCs can lose stemness and form more differentiated populations (12) . This bi-directionality among highly adaptable cells shapes the tumor with highly organized cell populations that directly impact disease evolution and prognosis (13) . The epithelial to mesenchymal transition (EMT) is a conserved embryonic developmental process that also occurs in cancer. during EMT, epithelial cells lose their typical adhesive characteristics while gaining properties more related to mesenchymal mobile cells (14) . The best-understood biomolecule associated with triggering EMT is TGF-β (transforming growth factor-β), and mounting evidence supports a TGF-β role in cancer cell invasion, metastasis, chemoresistance and relapse (15) . EMT has been shown to correlate with acquisition of a CSC-like phenotype (16, 17) , and circulating BrC cells often share characteristics of both stem-like cells and of EMT cells (18) .
In this study, we report dynamic interactions between BrC cells with different aggressive potential leading to lateral transmission of aggressive features. We used four BrC cell lines, two characterized by an epithelial phenotype and the inability to induce metastasis in mice (MCF-7 and T47d; identified therein as non-aggressive or NA-BrC cells) and two with a mesenchymal phenotype and highly metastatic potential (HS578T and MDA-MB-231; identified as highly aggressive or HA-BrC cells). We found that aggressive cells promoted an EMT/CSC-like and invasive phenotype in nonaggressive cells. Altogether, the experimental observations fit within a molecular regulatory network in which G-CSF, GM-CSF, IL-8 and MCP-1 inflammatory cytokines induce a stem-like invasive phenotype in NA-BrC cells, which respond increasing the activity of the CXCL12/CXCR4/CXCR7 chemokine signaling axis. . All patients and healthy controls were prospectively enrolled and were informed about the nature of the study. Those willing to participate signed a written informed consent prior to specimen collection and were treated according to the ethical guidelines and best clinical practice of our institution. The identity of the participants' names was anonymized for the duration of the study. Patients were on average 55.5 years old (range: 37-88), 22 were diagnosed with invasive ductal carcinoma, 2 with lobular and 4 with mixed carcinoma, and they had not received neoadjuvant therapy at the time of sample collection. All patients were classified as luminal A, luminal B, Her-2 positive and triple-negative and as clinical stages I, II, and III, except for 4 patients for whom we could not obtain this information. Consecutive numbers were given to the samples as they were collected.
Materials and methods

Cell
Induction of the invasive/stemness phenotype. BrC cells were plated at a density of 3x10 5 cells/ml/well in 6-well flat bottom culture plates. Once cells attached to the plate, supernatants were discarded, cells were rinsed with PBS 1X, and then cultured with 3 ml of conditioned media or with their respective media supplemented with 5, 10 or 20 ng/ml of human recombinant TGF-β (ref. Immunofluorescence. Cells (3x10 4 ) were seeded on coverslips for 24 h, the invasive/stemness phenotype was experimentally induced as explained above, after which cells were fixed with paraformaldehyde 4% for 10 min, and permeabilized with 0.2% Triton X-100 in PBS for 20 min. Cells were blocked for 1 h and then stained overnight at 4˚C with the primary antibodies: mouse monoclonal anti-E-cadherin 
Results
Aggressive breast cancer cells promote loss of E-cadherin and invasive features in non-aggressive cells. We defined MCF-7 and T47d ER-positive cells as NA-BrC cells and HS578T and
MdA-MB-231 triple-negative cells as HA-BrC cells based on expression of the EMT markers E-cadherin and vimentin and their invasive properties ( Fig. 1A and B) . In agreement, the former cell lines are non-metastatic in mouse, while the latter are highly metastatic in similar experimental conditions (19) . Since during metastasis cellular communication is importantly mediated by secreted factors (20) , we assessed whether NA-BrC cells cultured with conditioned media (CM) of HA-BrC cells, and vice-versa, modify each others aggressive characteristics. Fig. 1C shows that MCF-7 cells cultured with the HS578T CM reduced E-cadherin levels from a basal IOd of 22,000 to an IOd of 8,000, while with the CM of MdA-MB-231 cells E-cadherin levels were undetectable. This reduction of E-cadherin levels correlated well with an acquired capacity of cells to invade, observing an average of 10 and 30 MCF-7 invading cells/field when cultured in HS578T and MdA-MB-231 CMs, respectively. The same was true for T47D cells, finding a reduction of the E-cadherin IOD from 50,000 to <500, and 15-20 invading cells/field after culture with CM from aggressive cells (Fig. 1d) . On the contrary, no significant changes were observed in HA-BrC cells cultured with CM derived from NA-BrC cells (data no shown). Thus, these results support the capacity of aggressive tumor cells to laterally transmit aggressive features into non-aggressive cells, characterized by a partial EMT phenotype with reduction of E-cadherin but not significant induction of vimentin, and increased invasiveness.
CXCL12-CXCR4/CXCR7 axis in the inducible-invasive phenotype. CXCL12 is an essential chemokine often involved in the migration of BrC cells (21); similarly CXCL12 receptors CXCR4 and CXCR7, but also CXCR3 and CCR7 mediate metastasis of BrC cells (22) . To further explore the mechanism by which HA-BrC cells induce the migration of NA-BrC cells, we analyzed the concentration of CXCL12 in the CM of the BrC cells and the expression levels of the chemokine receptors on the NA-BrC cells treated with the CM of HA-BrC cells. Although high levels of CXCL12 were found in the CM of the BrC cell lines, no significant differences were found between aggressive and non-aggressive cells ( Fig. 2A) . Of the chemokine receptors, we found a discrete and more heterogeneous result with CXCR3, contrary to CXCR4, CXCR7 and CCR7 that significantly increased expression solely in response to HA-BrC CMs; CXCR4 and CXCR7 changed in both NA-BrC cells, while CCR7 only on induced T47d cells (Fig. 2B) . Since CXCR4 and CXCR7 are CXCL12 receptors, CXCL12 was tested as chemoattractant in invasion assays. We found that both induced invasive NA-BrC cells migrated in response to this chemokine (Fig. 2C) . To address whether the CM of aggressive cells could also attract cells, NA-BrC cells were cultured with the HA-BrC CMs as before, and then subjected to an invasive assay in which the same CM used to stimulate them was placed as chemoattractant in the lower chamber of the transwell cameras. We observed that the induced invasive MCF-7 and T47d cells were also migrating in response to the HA-BrC CMs, with MCF-7 cells seeming more responsive than T47d cells. In addition, the CM of MdA-MB-231 cells gave a more potent response than the CM of HS578T cells, with an average IOD/field of 900,000 for MCF-7 and 320,000 for T47d invading cells (Fig. 2d) . Cells did not invade in the absence of CXCL12 (data not shown). To confirm that CXCL12 had a role in the invasive phenotype, invasion assays were performed on the induced invasive MCF-7 and T47d cells using the CM of the BrC cell lines, either alone or plus a CXCL12 neutralizing antibody. We observed that the stimulated NA-BrC cells decreased their invasiveness in the presence of the inhibitory antibody (Fig. 2E) . These data support that the CM of HA-BrC cells induce migratory properties on NA-BrC cells together with upregulation of CXCR4 and CXCR7 expression, and that these induced invasive NA-BrC cells then move in response to CXCL12.
A TGF-β independent but G-CSF, GM-CSF, IL-8 and MCP-1 dependent response.
We addressed whether TGF-β was responsible for the inducible-invasive phenotype. When we quantified TGF-β levels in the CM of the BrC cell lines, we found a higher concentration of this cytokine in the CM of the HA-BrC cell lines (average of 343 and 377 pgs/ml in HS578T and MdA-MB-231 cells, respectively) than in the NA-BrC CMs (80 and 14 pgs/ml in T47d and MCF-7 cells, respectively) (Fig. 3A) . We then used a TGF-β neutralizing antibody to assess whether this cytokine was responsible for the inducible-invasive phenotype of NA-BrC cells. To do this, NA-BrC cells were stimulated for 72 h with CM from HA-BrC cells in the presence of the TGF-β neutralizing antibody. Surprisingly, when expression of E-cadherin was assessed we still observed a significant reduction of the E-cadherin IOD promoted by the HA-BrC CMs (Fig. 3B) . Similarly, the stimulated NA-BrC cells remain invasive in spite of the presence of the neutralizing antibody (Fig. 3C) . Additionally, we added exogenous TGF-β at various concentrations to MCF-7 and T47d cells for 72 h, with no observed variations in E-cadherin or vimentin expression. Accordingly, we did not observe a TGF-β-induced invasiveness (Fig. 3d) . TGF-β is known to induce its own expression in Caski cervical cancer cells (23). Exogenous TGF-β increased its own gene expression in Caski cells, and the neutralizing antibody abolished this induction, indicating that both recombinant TGF-β and the anti-TGF-β antibody were functional (data no shown).
We then analyzed for the presence of the following growth factors, cytokines, chemokines and matrix metalloproteinases Fig. 4A) . These cytokines are known to induce differentiation, proliferation and activation of myeloid cells recruited to the tumor microenvironment, and often, they also induce autocrine activation of tumor cells (26) (27) (28) . To assess whether these factors participate in the inducibleinvasive phenotype, MCF-7 and T47d cells were cultured in media supplemented with G-CSF, GM-CSF, IL-8 and MCP-1 for 72 h. We found that MCF-7 cells were highly responsive to these cytokines with G-CSF and GM-CSF inducing a partial loss, and IL-8 and MCP-1 an almost complete loss of E-cadherin levels ( Fig. 4B left plot) , we also observed that the expression of CXCR4 significantly increased in response to all cytokines while CXCR7 increased only in response to IL-8 and MCP-1 (Fig. 4C left plots) , which closely correlated with induction of invasiveness (Fig. 4d left panels) . Overall, these data show a great correlation between IL-8/MCP-1-induction of CXCR7 and E-cadherin reduction/increased invasion.
Somehow the results obtained with T47d cells were more complex. We only observed a very discreet but significant reduction of E-cadherin levels on T47D cells, and specifically upon stimulation with IL-8 and MCP-1 (Fig. 4B right plot) . We also observed an increase of CXCR4 expression in response to all cytokines, while CXCR7 increased expression only in response to IL-8 and MCP-1 (Fig. 4C right plots) . However, the T47d invasion assay was not as clear, since G-CSF, GM-CSF and MCP-1 were able to induce invasion but IL-8 was not (Fig. 4d right panels) . Of note, FBS was a more powerful chemoattractant of cytokine-activated T47d cells (Fig. 4E) , while CXCL12 was for MCF-7 cells (Fig. 4d) , even in cells stimulated with IL-8. A cocktail with all four cytokines did not further promote E-cadherin loss or increased invasion of NA-BrC cells (data not shown). Vimentin expression was not induced in these experimental conditions as we have previously observed with the HA-BrC CMs (data not shown and Fig. 1C and d ). Overall these data support an important role for GM-CSF, G-CSF, IL-8 and MCP-1 on the inducibleinvasive phenotype of NA-BrC cells, with an IL-8 and MCP-1 stronger activity on MCF-7 cells and a more variegated effect on T47d cells. Of note, these data point out that even though MCF-7 and T47d cells are highly plastic reacting to signals communicated by aggressive tumor cells, there are significant differences between the mechanisms of induced-aggressive behavior displayed by each cell line. We tested the concentration of CXCL12, G-CSF, GM-CSF, IL-8 and MCP-1 cytokines and of MMP-1 and MMP-2 metalloproteinases in sera of BrC patients (see Table I for the clinical characteristics of patients) and healthy controls, finding detectable levels of all analytes tested. Since we could only obtain five sera of each BrC subtype no statistical analysis was performed (Fig. 4F) .
CD44, Oct4 and Sox2 are upregulated in induced-invasive cells.
The hyaluronan receptor (also known as Cd44) has been widely associated with a CSC-like phenotype, and Oct-4 and Sox-2 are essential transcription factors involved in maintenance of pluripotency during embryogenesis, and their induced-expression has been evidenced in several types of cancer upon acquisition of metastatic potential and EMT (29, 30) . When we evaluated the expression of these CSC markers on the BrC cell lines we found that Cd44 positive cells were not (MCF-7=0% of positive cells) or rarely represented (T47d=2.83%) on NA-BrC cells, while they were highly represented on HS578T (90.8%) and MdA-MB-231 (96.1%) HA-BrC cells (Fig. 5A) . A similar observation was made for Oct-4 and Sox-2 (Fig. 5B) . We addressed whether the inducible-invasive trait correlated with acquisition of these stem markers. We found that both the frequency of Cd44 positive cells and the MFI of Cd44 expression were induced upon treatment with the HA-BrC CMs in both MCF-7 and T47d NA-BrC cells (Fig. 5C and d, respectively) . T47d cells were the most sensitive cells to stimulation as more than half of the cells expressed Cd44 upon treatment with the MdA-MB-231 CM. We also observed a significantly increased expression of Oct-4 and Sox-2 in MCF-7 cells upon stimulation with the CM from HA-BrC cell lines (Fig. 5E ). T47D cells significantly changed the expression of Sox-2 upon stimulation, while the levels of Oct-4 remained low (Fig. 5F) .
A more quantitative analysis of the frequency of Sox-2 expressing cells by flow cytometry confirmed the results obtained with the immunofluorescence analyses (Fig. 5G) . Since the formation of tumorspheres is a model of CSC seeding and expansion (31), we addressed the BrC cell lines basal and induced potential of formation of tumorspheres. We observed that all the cell lines exhibited similar capacities of formation of tumorospheres (Fig. 5H) , the only difference found was the morphology of the spheres, with HA-BrC cells forming less adherent spheres that resemble cell aggregates, typical of aggressive cell lines with low expression of adhesion proteins (32) . When NA-BrC cells were treated with the CM of HA-BrC cells, the frequency and morphology of the tumorspheres remained unchanged; however, spheres of increased size were observed (Fig. 5I) . Taken together all these data show that the inducible-invasive trait correlates with acquisition of a CSC-like phenotype defined by expression of CD44, Oct-4 and Sox-2 stemness markers, and also with the formation of larger tumorspheres in low adherent plates.
Discussion
The original conception of cancer initiation and progression highlighted the importance of accumulation of genetic mutations, with tumors exhibiting greater genetic heterogeneity also exhibiting an increased risk to display more aggressive features. More recent studies have also highlighted the capacity of the tumor to communicate with non-tumor cells within the tumor microenvironment as the source of aggression (5) . In this study, we evidenced a potential mechanism of paracrine communication between tumor cells that results in lateral transmission of aggressive features. The induced aggressive characteristics consist of acquisition of a partial EMT phenotype with loss of E-cadherin but without gain of vimentin expression, gain of CSC markers Cd44, Sox-2 and Oct-4, increased expression of CXCL12 receptors CXCR4 and CXCR7, and increased invasiveness in response to CXCL12. Altogether, these mechanisms of tumor communication may facilitate the appearance of new clones with novel functions, further extending the clonal heterogeneity that increases the tumor aggressive potential without relying on genetic irreversible mutations.
The clonal evolution model of tumors points out that distinct genetic clones exhibit differential fitness, and only those clones with specific advantages and under particular selective pressures will be maintained, favoring the progression of disease in a kind of darwinian evolution competition (33) . In 2014, Marusyk et al proposed that interactions between rare and affluent tumor clones favored the emergence of clones with novel phenotypes and functions allowing the tumor to adapt to microenvironmental changes (34) . Other studies support intra-clonal communication and cooperation, particularly among metastatic and non-metastatic clones (6, 7, 11) , adding another layer of complexity to the origin and evolution of tumors. The plasticity of the tumor cell has been extensively studied, with the EMT at the center of this plasticity. More recent evidence support that cancer cells undergoing EMT also increase expression of stem markers, and tumors in which the EMT/stemness programs are active, are also more invasive and metastatic denoting cancers with the worst clinical outcomes (16, 17, 24, 35, 36) . How the EMT and stemness programs support tumor heterogeneity and intraclonal coexistence to facilitate tumor maintenance remains as one of the most challenging puzzles in cancer biology. Interestingly, although TGF-β is one of the best characterized EMT triggers (15), we could not find any evidence of a TGF-β participation in the inducible invasive stem-like phenotype.
To our knowledge, Mani et al in 2008 were the first to describe a strong correlation between EMT and stemness (16) , laying the bases for a novel understanding of tumor plasticity and tumor aggression. Today, mounting evidence supports that association; for instance, BrCs with a high density of CD44-positive cells are specifically associated with reduced disease-free survival (37) . Expression of Oct-4 and Sox-2 is also associated with poor clinical outcomes in BrC patients (38, 39) . While we were working in this study, Mukherjee et al reported that CSCs with different capacities of migration co-exist within primary tumors and in MCF-7 mamospheres. Low migrating inner core CSCs have the capacity to induce migratory properties into outer core nonCSCs through paracrine secretion of EGF, TGF-β1, VEGF and IL-6 (11). In agreement with our study, induced non-CSCs showed increased expression of stemness markers Cd44, Oct-4 and Sox-2, and invasion was marked by upregulation of CXCR4. We observed an increased expression of CXCR4 and CXCR7 on induced-NA-BrC cell lines, which promoted cell migration in response to CXCL12, particularly in induced MCF-7 cells. In the case of T47d there is not a clear correlation that could be explained because contrary to MCF-7 cells, T47d cells also upregulate CXCR3 and CCR7 expression, as it can be observed in Fig. 2B . Still, the CXCR4/CXCR7/CXCL12 axis is widely documented as a potent promoter of invasion and metastasis in several types of cancer, and most likely also has an important role in the promotion of invasion of the induced-NA BrC cells (40, 41) .
Tumors with high density of CSCs are characterized by high expression of inflammatory mediators (42, 43) . We found that HA-BrC cell lines secret high levels of G-CSF, GM-CSF, MCP-1 and IL-8. Of them, MCP-1 and IL-8 were potent inducers of invasiveness of MCF-7 cells, and G-CSF, GM-CSF, IL-8 and MCP-1 of T47d cells. MCP-1 and IL-8 are considered critical pro-tumoral cytokines mainly because of their capacity to shape the TME by attracting immune cell populations (44, 45) . We have also observed that aggressive tumor cells are particularly proficient to attract monocytes/ macrophages through secretion of GM-CSF and MCP-1, and monocyte/macrophage co-cultivation with tumor cells further increase secretion of IL-8 and IL-1β (46) . Importantly, this study supports the capacity of tumor cells to secrete pro-inflammatory cytokines promoting stemness and invasion independent of other cellular components of the tumor stroma. In agreement, other studies support that autocrine overexpression of MCP-1 and IL-8 promotes tumor cell proliferation, migration, chemoresistance, metastasis and disease relapse (27, 28, 47) . In patients with breast and prostate cancers MCP-1 overexpression correlates with poor prognosis (48, 49) , and autocrine regulation of MCP-1 is associated with EMT, immunosuppression and metastasis (50) . Blocking MCP-1 in triple-negative BrC decreased the frequency and self-renewal potential of breast CSCs (51) . Other studies support an association between IL-8, MCP-1 and MMPs, and induction of CSCs and metastasis (24, 51, 52) . Of note, we also observed high levels of MMP-1 and MMP-2 secreted by HA-BrC cells.
In conclusion, our results support a model in which in a heterogeneous disease like cancer, highly aggressive tumor clones communicate with less aggressive clones through paracrine mediators, such as IL-8, MCP-1, G-CSF, GM-CSF and MMPs, transferring aggressive features in line with a CSC-like phenotype and increased potential for invasion (Fig. 6) . Although TGF-β remains the best-understood signal accountable for tumor cell plasticity, we could not find TGF-β participation in the inducible-invasive phenotype. Further studies should look into these pro-inflammatory factors in carefully staged BrC patients, comparing metastatic tumors against non-metastatic tumors or comparing other relevant clinical parameters, such as resistance to treatment, disease relapse and overall survival. We were unable to obtain the clinical data in our series of patients. Almost all the patients included in this study were classified as stage I and II, with only three patients in stage III and none in stage IV. Understanding the mechanisms guiding intra-tumoral heterogeneity, cell plasticity and tumor aggressiveness will provide better targets for diagnosis, prognosis and therapeutic strategies.
